Status
Conditions
About
Retrospectively and prospectively enrolled patients with cardiogenic shock in domestic manifolds and investigated the current state of treatment and clinical features of cardiogenic shock in Koreans and identified the factors that could improve the prognosis and the use of IABP and ECMO And to investigate its therapeutic effect.
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
19 years old or older
① Systolic blood pressure is less than 90mmHg for more than 30 minutes despite the fluid therapy, or Use of pressure boosting agents is necessary.
② Peripheral hypopnea (cold skin, urine less than 30 cc per hour, impaired consciousness, lactate ≥2.0 mmol / l) or a person with pulmonary edema.
Causes of cardiogenic shock include acute myocardial infarction (including in coronary intervention), cardiomyopathy, myocarditis, pulmonary embolism, refractory ventricular tachycardia, shock during coronary intervention.
Those voluntarily consenting to the medical records and the data necessary for the study during the entire study period.
Exclusion criteria
Loading...
Central trial contact
Jeong Hoon Yang; Jin Hee Seo
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal